Asano Y - Search Results

1

Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published work.

Takahashi T, Asano Y, Hirakawa M, Nakamura K, Saigusa R, Aozasa N, Sumida H, Fujita H, Sugaya M, Ohmori A, Shimizu J, Sato S. Takahashi T, et al. Among authors: asano y. J Dermatol. 2016 Oct;43(10):1224-1227. doi: 10.1111/1346-8138.13424. J Dermatol. 2016. PMID: 27129435 Review.

2

Serum levels of manganese superoxide dismutase in patients with localized scleroderma.

Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: asano y. Exp Dermatol. 2004 Jun;13(6):357-60. doi: 10.1111/j.0906-6705.2004.00160.x. Exp Dermatol. 2004. PMID: 15186321

3

Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.

Mimra Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K. Mimra Y, et al. Among authors: asano y. Int J Dermatol. 2005 Oct;44(10):817-20. doi: 10.1111/j.1365-4632.2005.02584.x. Int J Dermatol. 2005. PMID: 16207181

4

Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.

Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K. Asano Y, et al. J Invest Dermatol. 2006 Aug;126(8):1761-9. doi: 10.1038/sj.jid.5700331. Epub 2006 May 4. J Invest Dermatol. 2006. PMID: 16675963 Free article.

5

Linear connective tissue nevus.

Asano Y, Ihn H, Tamaki K. Asano Y, et al. Pediatr Dermatol. 2007 Jul-Aug;24(4):439-41. doi: 10.1111/j.1525-1470.2007.00477.x. Pediatr Dermatol. 2007. PMID: 17845185

6

Future treatments in systemic sclerosis.

Asano Y. Asano Y. J Dermatol. 2010 Jan;37(1):54-70. doi: 10.1111/j.1346-8138.2009.00758.x. J Dermatol. 2010. PMID: 20175840 Review.

7

A case of dermatomyositis with "liver disease associated with rheumatoid diseases" positive for anti-liver-kidney microsome-1 antibody.

Noda S, Asano Y, Tamaki Z, Takekoshi T, Sugaya M, Sato S. Noda S, et al. Among authors: asano y. Clin Rheumatol. 2010 Aug;29(8):941-3. doi: 10.1007/s10067-010-1397-3. Epub 2010 Feb 24. Clin Rheumatol. 2010. PMID: 20179980

8

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.

Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S. Yoshizaki A, et al. Among authors: asano y. Arthritis Rheum. 2010 Aug;62(8):2476-87. doi: 10.1002/art.27498. Arthritis Rheum. 2010. PMID: 20506342 Free article.

9

Serum CCL23 levels are increased in patients with systemic sclerosis.

Yanaba K, Yoshizaki A, Muroi E, Ogawa F, Asano Y, Kadono T, Sato S. Yanaba K, et al. Among authors: asano y. Arch Dermatol Res. 2011 Jan;303(1):29-34. doi: 10.1007/s00403-010-1078-8. Epub 2010 Sep 8. Arch Dermatol Res. 2011. PMID: 20824279

10

Serum levels of soluble CD21 in patients with systemic sclerosis.

Tomita M, Kadono T, Yazawa N, Kawashima T, Tamaki Z, Ashida R, Ohmatsu H, Asano Y, Sugaya M, Kubo M, Ihn H, Tamaki K, Sato S. Tomita M, et al. Among authors: asano y. Rheumatol Int. 2012 Feb;32(2):317-21. doi: 10.1007/s00296-010-1610-3. Epub 2010 Oct 30. Rheumatol Int. 2012. PMID: 21052675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,488 results

Search Page